Q27675 AF NFT

Receptor-type adenylate cyclase A

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeie3seq5txlgw6gx2nky7wu3p64vycdsrqbcet5lcq3hk357dqlq7y/metadata.json
IPFS of structure file: 
bafybeia7jrkif6y3ousa653fimwupxjiubkzuyc5sy2hv4b7macc6gsgti/AF-Q27675-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x8051013f297e33a0e3a4dAc3DB3d994eA9F283f4
First NFT owner address (bech32): 
genesis1spgsz0ef0ce6pcaymtpak0vef65l9ql5kdxser
Current NFT ID #82125 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
82125
Accession (UniProt):
Q27675
Name::
Receptor-type adenylate cyclase A
Experimental Method:
Predicted structure
Sequence source:
LEISHMANIA DONOVANI

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q27675 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q27675|CYAA_LEIDO Receptor-type adenylate cyclase A OS=Leishmania donovani OX=5661 GN=RAC-A PE=2 SV=1 MAMQIRPSLGGCLRHGGAGDHAARRLSRLRAAKVFVPTAVVCVLLCCAPWVMAEITNDAEREPVYILNAMYSTEAYTNEDAKALWTGMDMAFYNSHYKAAGGRPIKILHPDPDQDNLYDIAEVILHSLARQEKLLAVLGPYLDGRLTAALSNADVVQSGLMLIAPFTGSSGVRTWSDSVYFTRAEPMVELKVVLMHIVNRLRARRVAFMRLTGMHFGGEELTYVQDTLTSLLRDPAVLYTVPYSESSVEVDEEAFDAMADTNPQVIIVWAAPVQQVIYFLEKVLTDPRTSSAYVISCSMIQRVVFDVYKRLLSAGSIKPQDGRILASATTSPVSGEGLKYMEVLKAQMSNYIENSGSFDYYPDDDSTETLGRKARSEAPLSRKYTVDEFFQAHPSIAKLMALGWLSGTLVQQTLEQTDWIVNRSTYKAGLFNQNRFVIGGDYVLGDYGGPCEPLAQFLGASCYCNQGGHSSILTVLQNASWDIVPDSSFKYPQSECNSSKSQIVKAVSVLALLNQGYPKLIDAGMQLNEVLPHAFDDNLCKGYKVSSIFLRVETAKAQQLFDAEVSNYSVDIIAGPIFQALDVGEIFVLNPLYNHPQLRTEKRNYVYLMPTLEQQIYVMYSKIDALRTRTDVFEDTAVVLRGYSAQEVVEISEILFKTAGTFNLPDPSVATISFTDSLRGLLSPRAINVVIGMKDGDSAHFANFLAKYTDVMVVVCFDELTMYYEELRATFSVQPTSVQARLMSFSSLPLWTDASAEAKARWPILGHFHKIFPDPINHTPSLLRDVIIAGFIQELVSTTTVAETKLLTNAVYINGGVTTYGFTLGNFEWGCTATTSGDSCVYKNYGASNIEILSIQRMLDPTVPQLSSPSTPTMEYRPRQRSHALTPAQRNGLIAGCVVGAVVLIATCTLLLYCCMDNRNNDAAPKDGDEPVTLLFTDIESSTALWAALPQLMSDAIAAHHRVIRQLVKKYGCYEVKTIGDSFMIACRSAHSAVSLACEIQTKLLKHDWGTEALDRAYREFELARVDTLDDYEPPTARLSEEEYAALWCGLRVRVGIHTGLTDIRYDEVTKGYDYYGDTSNMAARTEAVANGGQVVATEAAWWALSNDERAGIAHTAMGPQGLRGVPFAVEMFQLNAVPGRRHAALRTEIEAILPDDTATDTASSAAGALLSSVETMSDPAAGIAFVLASCFAPYPVAQRVRELQPLLSKWGVGAPPRSRLVSEEDYCQGLMNRLAIRIATVSQARLRLTREDAADGKFKLASSEALNPLAREGDSAAGGVRPRLPGSPVTSLPAGGSSSMREWRVFTRLMNDTQHPSVTHLSQQRPSNLTSFTEAQDAAFPLNAHCGPESRVENSGADDEEIVIVRVSRNPHYARHAFE